Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

1yr ago Cannabis greenmarketreport Views: 230

-

The Daily Hit is a recap of the top financial news stories for February 6, 2023.

On the Site

Missouri Recreational Cannabis Opening Weekend Sales Near $13 Million

Over the first three-day weekend of legal recreational marijuana sales in Missouri, medical and adult-use retail sales combined to hit $12.6 million in sales, the state announced. Many shops reported long lines this past Friday. Read more here.

Georgia Medical Cannabis Program Rules Delayed over Technicality

The Georgia Access to Medical Cannabis Commission gathered for a special session on Thursday to roll back a unanimous approval they made last week regarding new major rules for their medical program. The commission forgot to notify the Office of Legislative Counsel about Jan. 25 meeting to pass testing, inspections, and distribution rules. Read more here.

Despite Early Access for Out-of-State Brands, In-State Hope Remains

In-state New York cannabis brands, especially smaller operations that are family run, might feel some apprehension about the news that out-of-state brands are already staking their claim in the Empire State’s legal marijuana market. Read more here.

Australia Legalizes Medicinal Use of Certain Psychedelics

The Australian government has signaled a new direction for the country’s view on psychedelics to treat certain mental health conditions. The Therapeutic Goods Administration (TGA) will reschedule medicines containing psilocybin and MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression. Read more here.

In Other News

Marijuana Packaging

The U.S. International Trade Commission’s chief administrative law judge has found that a variety of companies importing vaping cartridges don’t infringe a trio of patents. Judge Clark S. Cheney said Wednesday that he had issued a final initial determination in the Section 337 investigation, holding that there was no infringement of Shenzhen Smoore Technology’s patents. The reasoning for the decision is not yet available to the public and is subject to review by the agency’s commissioners. Read more here.

U.S. Cannabis Markets

Cannabis sales increased 5.3% in December compared to November according to cannabis data analytics firm BDSA. Looking at a per-day basis, sales increased 2.0% month-over-month. In total, BDSA estimates that sales across the 11 markets totaled $1.68 billion during the month. Read more here.

Daily Hit: February 6, 2023 on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.